OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response	112
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	111
Decoding the Intricacies of Statin-Associated Muscle Symptoms	51
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	43
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	42
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market	38
Deep Insight into the Role of MIF in Spondyloarthritis	37
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology	37
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know	35
AA Amyloidosis: A Contemporary View	31
Current perspective on infections and mitigation strategies in primary systemic vasculitis	29
The Role of Antiphospholipid Antibodies in COVID-19	29
Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review	29
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice	28
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review	28
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis	27
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development	27
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus	26
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis	25
Unveiling the Potential of Probiotics in Osteoarthritis Management	23
MRI in the Diagnosis and Treatment Response Assessment of Chronic Nonbacterial Osteomyelitis in Children and Adolescents	23
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases	23
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?	22
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention	22
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout	22

Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?	21
Updates on Clinical Trials in Systemic Lupus Erythematosus	21
An Update on the Diagnosis and Management of Calcium Crystal Disease	21
Epidemiology of Antiphospholipid Syndrome in the General Population	20
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis	20
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	19
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions	19
Newer Autoantibodies and Laboratory Assessments in Myositis	18
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis	18
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?	16
Advances in Juvenile Spondyloarthritis	16
Anti- Melanoma Differentiation-Associated Gene 5 Antibody Positive Dermatomyositis: Recent Progress in Pathophysiology and Treatment	16
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus	16
Digital Approaches for Myositis	16
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use	15
IgA Vasculitis in Adults: a Rare yet Challenging Disease	15
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management	15
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?	15
What to Know About Biopsy Sampling and Pathology in Vasculitis?	15
Spectrum of Spondyloarthritis Among Chinese Populations	14
Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies	14
Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	13
Enthesitis in Psoriatic Arthritis, the Sonographic Perspective	13
An Update on Kawasaki Disease	13
Syndesmophyte Growth in Ankylosing Spondylitis: from Laboratory to Bedside	13
From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis	12
Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus	12
Updating the 2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (SPARTAN 2024 Annual Meeting Proceedings)	12
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management	12
Gaining Insight into Updated MR Imaging for Quantitative Assessment of Cartilage Injury in Knee Osteoarthritis	12
Neuroimmune Mechanisms Underlying Post-acute Sequelae of SARS-CoV-2 (PASC) Pain, Predictions from a Ligand-Receptor Interactome	12
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature	11
Role of IFN-α in Rheumatoid Arthritis	11
Cannabis for Rheumatic Disease Pain: a Review of Current Literature	11
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes	10
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review	10
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings	10
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022	10
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies	10
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature	10
Mesangial Cells in Lupus Nephritis	10
Gout, Hyperuricemia and Psoriatic Arthritis: An Evolving Conundrum	10
What Has Dual Energy CT Taught Us About Gout?	9
Localized Forms of Vasculitis	9
The Interplay of Biomechanical and Biological Changes Following Meniscus Injury	9
Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis – SPARTAN 2024 Annual Meeting Proceedings	8
Axial Spondyloarthritis in Japan	8
Axial Spondyloarthritis and Diagnostic Challenges: Over-diagnosis, Misdiagnosis, and Under-diagnosis	8
Screening for Spondyloarthritis in Patients with Inflammatory Bowel Disease - SPARTAN 2024 Annual Meeting Proceedings	8
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	8

Hyperuricemia, Gout, and the Brain—an Update	8
Undifferentiated Connective Tissue Disease: Comprehensive Review	7
Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis	7
Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis	7
Systemic Lupus Erythematosus and COVID-19	7
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits	7
Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases	7
The Elusive Truth of Cannabinoids for Rheumatic Pain	6
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	6
Family Planning and Rheumatoid Arthritis	6
Biorepositories For Global Rare Disease Research: A Narrative Review	6
Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis	6
Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management	6
Trabecular Bone Score in Rheumatic Disease	6
An Update on Antiphospholipid Syndrome	6
Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	6
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review	6